Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women

Gynecologic Oncology

Volumn 98, Issue 1, 2005, Pages 63-67

  Garuti, Giancarlo ^a   Cellani, Fulvia ^a   Centinaio, Giovanna ^a   Sita, Giulia ^a   Nalli, Giulio ^a   Luerti, Massimo ^a  

^a Lodi Hospital   (Italy)

Author keywords

Breast cancer; Endometrial hyperplasia; Endometrial polyp; Endometrium; Hysteroscopy; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BODY MASS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CYTOLOGY; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENARCHE; MENOPAUSE; OUTPATIENT CARE; PARITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; TRANSVAGINAL ECHOGRAPHY;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ENDOMETRIUM; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 20444467989     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.03.036     Document Type: Article

References (33)

1. W.C. Willet, B. Rockhill, S.E. Hankinson, D.J. Hunter, and G.A. Colditz Epidemiology and non genetic causes of breast cancer J.R. Harris M.E. Lippman M. Morrow C.K. Osborne Diseases of the breast second ed. 2000 Lippincott Williams and Wilkins Philadelphia, PA, USA 175 220
2. L.A. Brinton, and R.N. Hoover Epidemiology of gynecological cancers W.J. Hoskins C.A. Perez R.C. Young Principles and practice of gynecologic oncology Third ed. 2000 Lippincott Williams and Wilkins Philadelphia, PA, USA 3 27
3. R.E. Curtis, J.D. Boice, D.A. Shriner, B.F. Hankey, and J.F. Fraumeni Second cancers after adjuvant therapy for breast cancer J. Natl. Cancer Inst. 88 1996 332 334
4. Early breast cancer trialists' collaborative group Tamoxifen for early breast cancer. An overview of the randomized trials Lancet 351 1998 1451 1467
5. B. Fisher, J. Dignam, N. Wolmark, D.L. Wickerham, E.R. Fisher, and E. Mamounas Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial Lancet 353 1999 1993 2000
6. B. Fisher, J.P. Costantino, D.L. Wickerman, C.K. Redmond, M. Kavanah, and W.M. Cronin Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study J. Natl. Cancer Inst. 90 1998 1371 1388
7. S.R. Goldstein Unusual sonographic appearance of the uterus in patients receiving tamoxifen Am. J. Obstet. Gynecol. 170 1994 447 451
8. F.A. Aleem, and M. Predonic Endometrial changes in patients on tamoxifen The Lancet 346 1995 1292 1293
9. Y. Daniel, M. Inbar, A. Bar-Am, M.R. Peyser, and J.B. Lessing The effects of tamoxifen treatment on the endometrium Fertil. Steril. 65 1996 1083 1089
10. F.E. Van Leewen, J. Benraadt, I.W.W. Coeherg, A.L.M. Klemeney, C.H.F. Gimbrere, and R. Otter Risk of endometrial cancer after tamoxifen treatment of breast cancer The Lancet 343 1994 448 452
11. H. Mignotte, C. Lasset, V. Bonadona, A. Lesur, E. Luporsi, and J.F. Rodier Iatrogenic risk of endometrium after treatment for breast cancer in a large French case-control study Int. J. Cancer 76 1998 325 330
12. B. Fisher, J.P. Costantino, C.K. Redmond, E.R. Fisher, D. Lawrence, and D.L. Wickerham Endometrial cancer in tamoxifen-treated patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 J. Natl. Cancer Inst. 86 1994 527 537
13. J. Cuzick, T. Powles, U. Veronesi, J. Forbes, R. Edwards, and S. Ashley Overview of the main outcomes in breast cancer prevention trials The Lancet 361 2003 296 300
14. P. Neven, X. DeMuyider, Y. VanBelle, I. VanHooff, and G. Vanderick Longitudinal hysteroscopic follow-up during tamoxifen treatment The Lancet 351 1998 36
15. M.A.G. Goncalves, N.J. Goncalves, M.M. Matias, A.C.P. Nazario, G. Rodrigues DeLima, and E.C. Baracat Hysteroscopic evaluation of the endometrium of postmenopausal patients with breast cancer before and after tamoxifen use Int. J. Gynecol. Obstet. 66 1999 273 279
16. M. Bèrliere, A. Charles, C. Galant, and J. Donnez Uterine side effects of tamoxifen; a need for systematic pretreatment screening Obstet. Gynecol. 91 1998 41 44
17. M. Vosse, F. Renard, M. Coiblon, P. Neven, J.M. Nogaret, and D. Hertens Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for a less intensive monitoring Eur. J. Obstet. Gynecol. Reprod. Biol. 101 2002 58 63
18. S. Duffy, T.L. Jackson, M. Lansdown, K. Philips, M. Wells, and S. Pollard The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data BJOG 110 2003 1099 2006
19. P. Neven, and H. Vernaeve Guidelines for monitoring patients taking tamoxifen treatment Drug Saf. 22 2000 1 9
20. M. Morrow, N.A. Fine, S.E. Singletary, A.S. Lichter, C.K. Osborne, and N.E. Davidson Primary treatment of invasive breast cancer J.R. Harris M.E. Lippman M. Morrow C.K. Osborne Diseases of the breast Second ed. 2000 Lippincott Williams and Wilkins Philadelphia, PA, USA 515 645
21. G. Garuti, I. Sambruni, M. Colonnelli, and M. Luerti Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women J. Am. Assoc. Gynecol. Laparosc. 8 2001 207 213
22. C.H. Buckley, and H. Fox Biopsy pathology of the endometrium L.S. Gottlieb A.M. Neville F. Walker Biopsy pathology series 14 1989 Chapman and Hall London
23. A.C. Fleischer, J.E. Wheeler, I. Lindsay, S.L. Hendrix, S. Grabill, and B. Kravitz An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms Am. J. Obstet. Gynecol. 184 2001 70 74
24. D.F. Areher, K. Melntyre-Seltman, and W.W. Wilborn Endometrial morphology in asymptomatic postmenopausal women Am. J. Obstet. Gynecol. 165 1991 317 322
25. M. Seoud, A. Shamseddine, A. Khalil, Z. Salem, N. Saghir, and K. Bikhazi Tamoxifen and endometrial pathology. A prospective study Gynecol. Oncol. 75 1999 15 19
26. R. Willen, B. Lindahl, E. Andolf, C. Ingvar, R. Liedman, and J. Ranstam Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen Anticancer Res. 18 1998 667 676
27. B. Gerber, A. Krouse, H. Muller, T. Reimer, T. Kulz, and J. Makovitzky Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound J. Clin. Oncol. 18 2000 3464 3470
28. G. Garuti, F. Cellani, F. Grossi, M. Colonnelli, G. Centinaio, and M. Luerti Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake Gynecol. Oncol. 86 2002 323 329
29. G. Garuti, F. Cellani, M. Colonnelli, G. Centinaio, D. Garzia, and C. Gonfiantini Tamoxifen-associated endometrial pathology in menopausal asymptomatic women with breast cancer, sonographic and hysteroscopic correlates Int. J. Gynecol. Obstet. 15 2003 47 55
30. B.B. Love, B.B. Muir, J.B. Scrimegeour, R.C.F. Leonard, P. Dillon, and J.M. Dixon Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening J. Clin. Oncol. 17 1999 2050 2054
31. E. Lahti, G. Blanco, A. Kauppila, M. Apaja-Sakkinen, P.J. Taskinen, and T. Laatikainen Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen Obstet. Gynecol. 81 1993 660 664
32. M. Juneja, R. Jose, A.N. Kekre, L. Viswanathan, and L. Seshadri Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma Int. J. Gynecol. Obstet. 76 2002 279 284
33. K. Katase, Y. Sugijama, K. Hasumi, M. Yoshimoto, and F. Kasumi The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma Cancer 82 1998 1696 1703